We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The University of Dundee’s drug discovery unit (DDU) has formed an alliance with Korea-based Bukwang Pharmaceutical for the development of a drug to treat Parkinson’s disease.
Boehringer Ingelheim has extended a collaboration with the University of Dundee in Scotland for the development of proteolysis targeting chimera (PROTAC) based drugs to treat cancer.